Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively kills various cancer cell types, but also leads to the activation of signaling pathways that favor resistance to cell death. Here, we investigated the as yet unknown roles of calcium signaling and autophagy regulatory proteins during TRAIL-induced cell death in leukemia cells. Taking advantage of the Gene Expression Profiling Interactive Analysis (GEPIA) project, we first found that leukemia patients present a unique TRAIL receptor gene expression pattern that may reflect their resistance to TRAIL. The exposure of NB4 acute promyelocytic leukemia cells to TRAIL induces intracellular Ca2+ influx through a calcium release-activated channel (CRAC)-dependent mechanism, leading to an anti-apoptotic response. Mechanistically, we showed that upon TRAIL treatment, two autophagy proteins, ATG7 and p62/SQSTM1, are recruited to the death-inducing signaling complex (DISC) and are essential for TRAIL-induced Ca2+ influx and cell death. Importantly, the treatment of NB4 cells with all-trans retinoic acid (ATRA) led to the upregulation of p62/SQSTM1 and caspase-8 and, when added prior to TRAIL stimulation, significantly enhanced DISC formation and the apoptosis induced by TRAIL. In addition to uncovering new pleiotropic roles for autophagy proteins in controlling the calcium response and apoptosis triggered by TRAIL, our results point to novel therapeutic strategies for sensitizing leukemia cells to TRAIL.

Highlights

  • Ca2+ response, we studied the effects of autophagy (ATG7) depletion on endoplasmic reticulum (ER) Ca2+ homeostasis

  • Jia et al [48] reported that the impairment of the Ca2+ influx in autophagydeficient Jurkat cells resulted from abnormal ER expansion and enhanced ER Ca2+ control and ATG7-KO NB4 cells with the Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA)

  • We demonstrated a new role for the autophagy proteins ATG7 and p62 in regulating calcium release-activated channel (CRAC)-dependent Ca2+ influx and ER calcium homeostasis in acute promyelocytic leukemia (APL) cells treated with Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

Read more

Summary

Introduction

The binding of TRAIL to its cognate receptors enables a plethora of cellular responses that can either contribute to tumor immunosurveillance or tumor development and metastasis in a cancer context-dependent manner [2,3,4]. TRAIL signaling is mainly transmitted through its interaction with receptor homotrimers: TRAIL-R1 (DR4) and TRAIL-R2 (DR5) contribute to extrinsic pathway apoptosis, while. TRAIL-R3 (DcR1) and TRAIL-R4 (DcR2) act mostly as putative TRAIL-neutralizing decoy receptors [5,6]. The binding of TRAIL to its cognate receptors DR4 or DR5 induces the assembly of a death-inducing signaling complex (DISC), in which the apoptosis initiator procaspase-8 (proCASP-8) is brought close of the intracellular death domain (DD)

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.